(R)-Pirtobrutinib

Overview

(R)-Pirtobrutinib ((R)-LOXO-305) is a less active enantiomer of Pirtobrutinib. Pirtobrutinib (LOXO-305), a highly selective and non-covalent next generation BTK inhibitor , inhibits diverse BTK C481 substitution mutations.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Autoimmune Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Others | Products > Signaling Pathways > Btk

Product Information

• Catalog No.: HY-131328A
• CAS No.: 2101700-14-3
• Molecular Formula: C22H21F4N5O3
• Molecular Weight: 479.43
• Purity: 99.78%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (10.43 mM); Clear solution
• Availability: In-stock

Source

Original product source